The impact of continuous glucose monitoring on the management of people with cystic fibrosis-related diabetes

Aileen Toner
Background Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity found in people with cystic fibrosis (pwCF). CFRD is associated with increased adverse outcomes and burden of treatment in pwCF as well as reduced quality of life. People with CFRD (pwCFRD) must measure their blood glucose levels several times per day to monitor their diabetes and so that treatment can be tailored to individuals. Continuous glucose monitoring systems (CGMS) are a relatively new technology that...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.